Abbott wins U.S. emergency use authorization for new Covid-19 antibody test
Coronavirus stimulus checks: Trump may back package larger than Democrats’ bill, Kudlow says
Blue Tower Asset Management 3Q20 Commentary: Berry Global Group
UK biotech sector sets new record with more than £1bn investment in Q3
Morgan Stanley: 2 Stocks That Could Climb Over 40%
Senate Republicans Will Back Trump On Stimulus, White House Claims
Coronavirus stimulus checks: Many Senators object to White House’s latest offer
COVID-19 will probably become endemic – here's what that means
Coronavirus: R number does not measure risk – financial disaster modelling offers a better alternative
US Dollar Flat As Investors Weigh Fiscal Stimulus Talks, Wait for Inflation Data
Key Events This Week: Earnings Season Begins, CPI And Retail Sales
Coronavirus stimulus checks: Pelosi rejects Trump’s $1.8T offer, calls it ‘Grossly Inadequate’
New California Financial Watchdog Would Take Aim At Predatory Lenders Amid Pandemic
Mirae launches five ‘New Deal’ thematic equity ETFs on KRX
Investing During Periods of Uncertainty & Turmoil
3 COVID-19 Antibody Stocks That Are Leading the Race
USD/JPY falls to 1-week low
Spotlight on COVID-19 antibody therapies after Trump’s recovery
Futures Jump, Near Record High On "Stimulus, Earnings Optimism"
As COVID-19 cases rise again, how will the US respond? Here's what states have learned so far
Remdesivir study finally published – an expert in critical care medicine gives us his verdict
GM China 3Q Vehicle Sales Jump 12%; Merrill Lynch Sees 87% Upside
Hundreds Of Bars To Close As BoJo Backs Tough New 'Localized' Lockdowns: Live Updates
Yuan in Spotlight in Consolidative Session
Opko’s BioReference Lab Begins Covid-19 Testing At NYC Schools
Kymera Therapeutics Pops 10% On Positive Skin Disorder Data
Eli Lilly In Gates Foundation Supply Deal For Covid-19 Antibodies
Exclusive interview: In talks with Chairman of the Financial Commission, Peter Tatarnikov
Weekly Market Outlook: Trump stimulus and global economic data in focus
Pfizer, BioNTech Initiate Rolling Canada Submission For Covid-19 Vaccine